Engineering large viral DNA genomes using the CRISPR-Cas9 system

Microbiology and Immunology

Volumn 58, Issue 9, 2014, Pages 513-522

  Suenaga, Tadahiro ^a,b   Kohyama, Masako ^a,b   Hirayasu, Kouyuki ^a,b   Arase, Hisashi ^a,b,c  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Clustered regularly interspaced short palindromic repeat Cas9; Genome engineering; Herpes simplex virus; Large viral genome

Indexed keywords

NUCLEASE; PROTEIN CAS9; UNCLASSIFIED DRUG; VIRUS DNA; DNA VIRUS;

ARTICLE; CLONE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; EMBRYO; GENE TARGETING; GENETIC ENGINEERING; GENOME SIZE; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; VIRUS GENOME; VIRUS MUTATION; GENETIC RECOMBINATION; GENETICS; PROCEDURES; SIMPLEXVIRUS; VIROLOGY;

CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; DNA VIRUSES; GENETIC ENGINEERING; GENOME, VIRAL; HUMANS; RECOMBINATION, GENETIC; SIMPLEXVIRUS; VIROLOGY;

EID: 84906814461     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12180     Document Type: Article

References (32)

1. Post L.E., Roizman B. (1981) A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth. Cell 25: 227-32.
2. Almazan F., Gonzalez J.M., Penzes Z., Izeta A., Calvo E., Plana-Duran J., Enjuanes L. (2000) Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci USA 97: 5516-21.
3. Domi A., Moss B. (2002) Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells. Proc Natl Acad Sci USA 99: 12415-20.
4. Luckow V.A., Lee S.C., Barry G.F., Olins P.O. (1993) Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J Virol 67: 4566-79.
5. Messerle M., Crnkovic I., Hammerschmidt W., Ziegler H., Koszinowski U.H. (1997) Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci USA 94: 14759-63.
6. O'connor M., Peifer M., Bender W. (1989) Construction of large DNA segments in Escherichia coli. Science 244: 1307-12.
7. Tanaka M., Kagawa H., Yamanashi Y., Sata T., Kawaguchi Y. (2003) Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J Virol 77: 1382-91.
8. Zhang Y., Buchholz F., Muyrers J.P., Stewart A.F. (1998) A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet 20: 123-8.
9. Garneau J.E., Dupuis M.E., Villion M., Romero D.A., Barrangou R., Boyaval P., Fremaux C., Horvath P., Magadan A.H., Moineau S. (2010) The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468: 67-71.
10. Horvath P., Barrangou R. (2010) CRISPR/Cas, the immune system of bacteria and archaea. Science 327: 167-70.
11. Wiedenheft B., Sternberg S.H., Doudna J.A. (2012) RNA-guided genetic silencing systems in bacteria and archaea. Nature 482: 331-8.
12. Deltcheva E., Chylinski K., Sharma C.M., Gonzales K., Chao Y., Pirzada Z.A., Eckert M.R., Vogel J., Charpentier E. (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471: 602-7.
13. Deveau H., Garneau J.E., Moineau S. (2010) CRISPR/Cas system and its role in phage-bacteria interactions. Annu Rev Microbiol 64: 475-93.
14. Gasiunas G., Barrangou R., Horvath P., Siksnys V. (2012) Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA 109: E2579-86.
15. Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J.A., Charpentier E. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-21.
16. Cho S.W., Kim S., Kim J.M., Kim J.S. (2013) Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31: 230-2.
17. Cong L., Ran F.A., Cox D., Lin S., Barretto R., Habib N., Hsu P.D., Wu X., Jiang W., Marraffini L.A., Zhang F. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-23.
18. Mali P., Yang L., Esvelt K.M., Aach J., Guell M., Dicarlo J.E., Norville J.E., Church G.M. (2013) RNA-guided human genome engineering via Cas9. Science 339: 823-6.
19. Wang H., Yang H., Shivalila C.S., Dawlaty M.M., Cheng A.W., Zhang F., Jaenisch R. (2013) One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153: 910-8.
20. Chang N., Sun C., Gao L., Zhu D., Xu X., Zhu X., Xiong J.W., Xi J.J. (2013) Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res 23: 465-72.
21. Gratz S.J., Cummings A.M., Nguyen J.N., Hamm D.C., Donohue L.K., Harrison M.M., Wildonger J., O'connor-Giles K.M. (2013) Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 194: 1029-35.
22. Friedland A.E., Tzur Y.B., Esvelt K.M., Colaiacovo M.P., Church G.M., Calarco J.A. (2013) Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods 10: 741-3.
23. Nekrasov V., Staskawicz B., Weigel D., Jones J.D., Kamoun S. (2013) Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease. Nat Biotechnol 31: 691-3.
24. Dicarlo J.E., Norville J.E., Mali P., Rios X., Aach J., Church G.M. (2013) Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res 41: 4336-43.
25. Satoh T., Arii J., Suenaga T., Wang J., Kogure A., Uehori J., Arase N., Shiratori I., Tanaka S., Kawaguchi Y., Spear P.G., Lanier L.L., Arase H. (2008) PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 132: 935-44.
26. Johnson D.C., Feenstra V. (1987) Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. J Virol 61: 2208-16.
27. Johnson D.C., Frame M.C., Ligas M.W., Cross A.M., Stow N.D. (1988) Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol 62: 1347-54.
28. Elion G.B., Furman P.A., Fyfe J.A., De Miranda P., Beauchamp L., Schaeffer H.J. (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci USA 74: 5716-20.
29. Schaeffer H.J., Beauchamp L., De Miranda P., Elion G.B., Bauer D.J., Collins P. (1978) 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature 272: 583-5.
30. Ran F.A., Hsu P.D., Lin C.Y., Gootenberg J.S., Konermann S., Trevino A.E., Scott D.A., Inoue A., Matoba S., Zhang Y., Zhang F. (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154: 1380-9.
31. Bi Y., Sun L., Gao D., Ding C., Li Z., Li Y., Cun W., Li Q. (2014) High-efficiency targeted editing of large viral genomes by rna-guided nucleases. PLoS Pathog 10: e1004090.
32. Ebina H., Misawa N., Kanemura Y., Koyanagi Y. (2013) Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 3: 2510.